These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Improved orthostatic tolerance in familial amyloidotic polyneuropathy with unnatural noradrenaline precursor L-threo-3,4-dihydroxyphenylserine. Carvalho MJ, van den Meiracker AH, Boomsma F, Man in 't Veld AJ, Freitas J, Costa O, de Freitas AF. J Auton Nerv Syst; 1997 Jan 12; 62(1-2):63-71. PubMed ID: 9021651 [Abstract] [Full Text] [Related]
14. L-dihydroxyphenylserine (Droxidopa) in the treatment of orthostatic hypotension: the European experience. Mathias CJ. Clin Auton Res; 2008 Mar 12; 18 Suppl 1():25-9. PubMed ID: 18368304 [Abstract] [Full Text] [Related]
15. Studies of neurocirculatory effects of long-term L-threo-3,4-dihydroxyphenylserine administration in a patient with familial amyloidotic polyneuropathy. Azuma T, Suzuki T, Mizuno R, Tsujino S, Kishimoto S, Mizuta E, Ichikawa K. Acta Neurol Scand; 1988 May 12; 77(5):409-13. PubMed ID: 3137768 [Abstract] [Full Text] [Related]
19. The effects of the noradrenaline precursor, L-threo-3,4-dihydroxyphenylserine, in children with orthostatic intolerance. Tanaka H, Yamaguchi H, Mino M. Clin Auton Res; 1996 Aug 12; 6(4):189-93. PubMed ID: 8902314 [Abstract] [Full Text] [Related]